Prevalence and determinants of controlled hypertension in a German population cohort
| Autor: | Neeltje van den Berg, Sebastian E. Baumeister, Wolfgang Hoffmann, Claudia Meinke-Franze, Thomas Fiss |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
Adult
Male medicine.medical_specialty Pediatrics Study of Health in Pomerania (SHIP) epidemiology [Germany] Blood Pressure Ethnic Groups Comorbidity epidemiology [Hypertension] Cohort Studies Determinants of normotensive blood pressure Germany Antihypertensive treatment Epidemiology Ethnicity medicine Prevalence Humans complications [Stroke] ddc:610 administration & dosage [Antihypertensive Agents] complications [Hypertension] Antihypertensive Agents Aged Aged 80 and over business.industry Public health Public Health Environmental and Occupational Health Middle Aged medicine.disease drug therapy [Hypertension] drug effects [Blood Pressure] Stroke Blood pressure Logistic Models Diabetes Mellitus Type 2 Study of Health in Pomerania Hypertension Cohort Female Biostatistics business complications [Diabetes Mellitus Type 2] Research Article Demography Cohort study |
| Zdroj: | BMC public health 13(1), 594 (2013). doi:10.1186/1471-2458-13-594 BMC Public Health |
| ISSN: | 1471-2458 |
| DOI: | 10.1186/1471-2458-13-594 |
| Popis: | Background Data of the German population-based cohort SHIP (Study of Health in Pomerania) were analysed to examine treatment rates, antihypertensive substances prescribed, and the proportion of hypertensive study participants reaching target values for blood pressure as well as determinants. Methods The study population was defined using baseline data of the cohort (collected between 1997 and 2001). Participants with blood pressure values ≥140/90 mmHg and/or antihypertensive medication with known hypertension and participants with risk-comorbidity (diabetes, stroke, angina pectoris, and/or myocardial infarction) and blood pressure values ≥130/80 mmHg were included. The analysis of treatment and target values was based on the 5-year follow-up of the cohort (collected between 2002 and 2006). Logistic regression was used to identify determinants for a normotensive blood pressure. Results 3278 SHIP-participants with hypertensive blood pressure values were included (mean age: 55.5 years; SD 13.6, range 21–80 years). The raw hypertension prevalence was 50.9% (N = 1761). 58.7% (N = 1074) of all hypertensive patients reported some form of antihypertensive treatment. Thereof 65.1% (N = 728) received combination therapy. Of the patients without risk-comorbidity, 42.1% (N = 489) reached their target blood pressure values at the time of the 5-year follow-up of the cohort. Of the patients with any risk-comorbidity this proportion was only 21.7% (N = 131). Significant determinants for reaching the target values were being female and having antihypertensive combination therapy. Increasing age, having risk-comorbidities, and obesity were negatively associated with reaching the target values. Conclusions Both the proportion of participants receiving therapy and the number of participants reaching their target blood pressure values are very low. Combination therapy is associated with better blood pressure control as compared to mono therapy. However, even in the subgroup of hypertensive patients under combination therapy only 36% (both patients with and without comorbidity) reach target values. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|